4453 Total Publications
Multilocus genetic profiling to empower drug trials and predict brain atrophy.
Kohannim, O., Hua, X., Rajagopalan, P., Hibar, D. P., Jahanshad, N., Grill, J. D., … Thompson, P. M.
PMID: 24179834
;
PMCID:3777716
; 2013; Journal Neuroimage: Clinical; vol. 2; pp. 827-35;
doi:10.1016/j.nicl.2013.05.007
Alzheimer’s Disease Risk Assessment Using Large-Scale Machine Learning Methods
Casanova, R., Hsu, F.-C., Sink, K. M., Rapp, S. R., Williamson, J. D., Resnick, S. M., & Espeland, M. a.
PMID: 24250789
;
PMCID:3826736
; 2013; Journal PloS One; vol. 8; pp. e77949;
doi:10.1371/journal.pone.0077949
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia
Arbizu, J., Prieto, E., Martínez-Lage, P., Martí-Climent, J. M., García-Granero, M., Lamet, I., … Weiner, M. W.
PMID: 23715905
; 2013; Journal European Journal of Nuclear Medicine and Molecular Imaging; vol. 40; no. 9; pp. 1394-1405;
doi:10.1007/s00259-013-2458-z
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
Cruchaga, C., Kauwe, J. S. K., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., … Goate, A. M.
PMID: 23562540
;
PMCID:3664945
; 2013; Journal Neuron; vol. 78; no. 2; pp. 256-68;
doi:10.1016/j.neuron.2013.02.026
Disease progression model in subjects with mild cognitive impairment from the Alzheimer’s disease neuroimaging initiative: CSF biomarkers predict population subtypes.
Samtani, M. N., Raghavan, N., Shi, Y., Novak, G., Farnum, M., Lobanov, V., … Narayan, V. a.
2013; Journal British Journal of Clinical Pharmacology; vol. 75; no. 1; pp. 146-161;
doi:10.1111/j.1365-2125.2012.04308.x
Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Ourselin, S., & Fox, N. C.
2013; Journal Neurology; vol. 80; no. 7; pp. 648-54;
doi:10.1212/WNL.0b013e318281ccd3
White matter hyperintensities and cerebral amyloidosis: Necessary and sufficient for clinical expression of Alzheimer’s disease?
Provenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., … Brickman, A. M.
PMID: 23420027
;
PMCID:4124641
; 2013; Journal JAMA Neurology; vol. 70; no. 4; pp. 455-461;
doi:10.1001/jamaneurol.2013.1321